83
Views
22
CrossRef citations to date
0
Altmetric
Special Report

Emerging therapies for melanoma

&
Pages 553-560 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Kalyani Prusty & Sarat K. Swain. (2018) Nanostructured chitosan composites for cancer therapy: A review. International Journal of Polymeric Materials and Polymeric Biomaterials 67:15, pages 879-888.
Read now
Jiezhong Chen, Renfu Shao, Xu Dong Zhang & Chen Chen. (2013) Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. International Journal of Nanomedicine 8, pages 2677-2688.
Read now
Jinfeng Wu, Jinhua Xu, ErikaA. Eksioglu, Xianghong Chen, Junmin Zhou, Nicole Fortenbery, Sheng Wei & Jingcheng Dong. (2013) Icariside II Induces Apoptosis of Melanoma Cells Through the Downregulation of Survival Pathways. Nutrition and Cancer 65:1, pages 110-117.
Read now

Articles from other publishers (19)

Jianxiu Lu, Wenjuan Wang, Ze Xu, Peiying Zhang, Jiake Gu, Zhilong Xu, Juqun Xi & Lei Fan. (2023) CaCO3-assistant synthesis of pH/near-infrared light-responsive and injectable sodium alginate hydrogels for melanoma synergistic treatment. Journal of Colloid and Interface Science 633, pages 657-667.
Crossref
Yi Yu, Yuanyuan Ren, Caihua Wang, Zhuozhuo Li, Fanglin Niu, Zi Li, Qiang Ye, Jiangxia Wang, Yuan Yan, Ping Liu, Lu Qian & Yuyan Xiong. (2022) Arginase 2 negatively regulates sorafenib-induced cell death by mediating ferroptosis in melanoma. Acta Biochimica et Biophysica Sinica.
Crossref
Lanlan Wang, Li Wang, Yang Zhang, Zhiyu Zhao, Cong Liu, Mengqi Li, Jiajing Liu, Shengyu Wang, Dong Yang, Fanghong Luo & Jianghua Yan. (2022) LS-HB-Mediated Photodynamic Therapy Inhibits Proliferation and Induces Cell Apoptosis in Melanoma. Molecular Pharmaceutics 19:7, pages 2607-2619.
Crossref
Khalaf A. Jasim, Ibrahim F. Waheed, Martin Topps & Andre J. Gesquiere. (2021) Multifunctional system for combined chemodynamic–photodynamic therapy employing the endothelin axis based on conjugated polymer nanoparticles. Polymer Chemistry 12:38, pages 5449-5466.
Crossref
Vijay Sagar Madamsetty, Manash K. Paul, Anubhab Mukherjee & Sudip Mukherjee. (2019) Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics. ACS Biomaterials Science & Engineering 6:1, pages 167-181.
Crossref
Khalaf A. Jasim & Andre J. Gesquiere. (2019) Ultrastable and Biofunctionalizable Conjugated Polymer Nanoparticles with Encapsulated Iron for Ferroptosis Assisted Chemodynamic Therapy. Molecular Pharmaceutics 16:12, pages 4852-4866.
Crossref
J. Chen & X.D. Zhang. 2016. Nanoscience in Dermatology. Nanoscience in Dermatology 189 201 .
BASKAR SUBRAMANI, CHITHRA RAMANATHAN PULLAI, KOHILA KRISHNAN, SHEELA DEVI SUGADAN, XUEWEN DENG, TERUNUMA HIROSHI & KANANATHAN RATNAVELU. (2014) Efficacy of ex vivo activated and expanded natural killer cells and T lymphocytes for colorectal cancer patients. Biomedical Reports 2:4, pages 505-508.
Crossref
SubbaRao V. Madhunapantula, Arati Sharma, Raghavendra Gowda & Gavin P. Robertson. (2013) Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma. Pigment Cell & Melanoma Research 26:6, pages 886-899.
Crossref
Natalie Nguyen, Arati Sharma, Nhung Nguyen, Arun K. Sharma, Dhimant Desai, Sung Jin Huh, Shantu Amin, Craig Meyers & Gavin P. Robertson. (2011) Melanoma Chemoprevention in Skin Reconstructs and Mouse Xenografts Using Isoselenocyanate-4. Cancer Prevention Research 4:2, pages 248-258.
Crossref
Gajanan S. Inamdar, SubbaRao V. Madhunapantula & Gavin P. Robertson. (2010) Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail. Biochemical Pharmacology 80:5, pages 624-637.
Crossref
Jose Prados, Consolación Melguizo, Raúl Ortiz, Houria Boulaiz, Esmeralda Carrillo, Ana Segura, Jose Juan Rodríguez‐Herva, Juan Luis Ramos & Antonia Aránega. (2010) Regression of established subcutaneous B16‐F10 murine melanoma tumors after gef gene therapy associated with the mitochondrial apoptotic pathway . Experimental Dermatology 19:4, pages 363-371.
Crossref
Tao Sun, Nan Zhao, Chun-sheng Ni, Xiu-lan Zhao, Wen-zhi Zhang, Xin Su, Dan-fang Zhang, Qiang Gu & Bao-cun Sun. (2009) Doxycycline inhibits the adhesion and migration of melanoma cells by inhibiting the expression and phosphorylation of focal adhesion kinase (FAK). Cancer Letters 285:2, pages 141-150.
Crossref
Raúl Ortiz, Jose Prados, Consolacion Melguizo, Ana R. Rama, Ana Segura, Fernando Rodríguez-Serrano, Houria Boulaiz, Fidel Hita, Antonio Martinez-Amat, Roberto Madeddu, Juan L. Ramos & Antonia Aranega. (2009) The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo. Journal of Molecular Medicine 87:9, pages 899-911.
Crossref
Joseph Califano & Melonie Nance. (2009) Malignant Melanoma. Facial Plastic Surgery Clinics of North America 17:3, pages 337-348.
Crossref
Claudia Jursik, Michaela Prchal, Regina Grillari-Voglauer, Karel Drbal, Elke Fuertbauer, Herbert Jungfer, Winfried H. Albert, Eva Steinhuber, Thomas Hemetsberger, Johannes Grillari, Hannes Stockinger & Hermann Katinger. (2009) Large-Scale Production and Characterization of Novel CD4+ Cytotoxic T Cells with Broad Tumor Specificity for Immunotherapy. Molecular Cancer Research 7:3, pages 339-353.
Crossref
Arati Sharma, Arun K. Sharma, SubbaRao V. Madhunapantula, Dhimant Desai, Sung Jin Huh, Paul Mosca, Shantu Amin & Gavin P. Robertson. (2009) Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates. Clinical Cancer Research 15:5, pages 1674-1685.
Crossref
Lucia Jilaveanu, Christopher Zito, Sandra J. Lee, Katherine L. Nathanson, Robert L. Camp, David L. Rimm, Keith T. Flaherty & Harriet M. Kluger. (2009) Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib. Clinical Cancer Research 15:3, pages 1076-1085.
Crossref
Kevin N. O'Regan, Conor O. Bogue, Mark Corrigan, H. P. Redmond & Josephine E. Barry. (2008) CT Imaging of Metastatic Malignant Melanoma. Contemporary Diagnostic Radiology 31:18, pages 1-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.